News
-
-
PRESS RELEASE
The Diabetes Research Institute, University of Miami, Announces Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes at ADA 2024
iTolerance Inc. announces breakthrough results with innovative approach combining human stem cell-derived islets and immunomodulatory microgel to reverse Type 1 Diabetes, presented at ADA's 84th Scientific Sessions -
PRESS RELEASE
iTolerance, Inc. to Present at Biotech Showcase(TM) 2024
iTolerance, Inc. has announced that Dr. Anthony Japour, Chief Executive Officer, will present at Biotech Showcase™ 2024 on January 8, 2024, at 11:30 AM PT in San Francisco, CA. The event provides an opportunity for the company to connect with investors and pharmaceutical executives and features multiple tracks of presenting companies, plenary sessions, and networking. iTolerance is focused on developing regenerative medicines, with the potential to cure diseases. For more information about the event, please visit the conference website. -
-
